MEDICUS PHARMA LTD. Operating Lease, Payments
MEDICUS PHARMA LTD. (MDCX) reported Operating Lease, Payments of $76.95 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-12
- MEDICUS PHARMA LTD. operating lease, payments for the quarter ending 2026-06-30 was $40.86K, a 16.61% increase year-over-year.
- MEDICUS PHARMA LTD. operating lease, payments for the quarter ending 2026-03-31 was $36.09K, a 3.00% increase year-over-year.
- MEDICUS PHARMA LTD. operating lease, payments for the quarter ending 2025-12-31 was $36.44K, a 4.00% increase year-over-year.
- MEDICUS PHARMA LTD. operating lease, payments for the quarter ending 2025-09-30 was $36.09K, a 3.00% increase year-over-year.
- MEDICUS PHARMA LTD. operating lease, payments for fiscal 2025 was $142.61K, a 103.50% increase from fiscal 2024.
- MEDICUS PHARMA LTD. operating lease, payments for fiscal 2024 was $70.08K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $76.95K 10-Q · filed 2026-08-12 | $113.39K derived: sum of 3 quarters · filed 2026-08-12 | $149.48K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $36.09K 10-Q · filed 2026-05-14 | $72.53K derived: sum of 2 quarters · filed 2026-05-14 | $108.62K derived: sum of 3 quarters · filed 2026-05-14 | $143.66K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $36.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $72.53K derived: sum of 2 quarters · filed 2026-03-25 | $107.57K derived: sum of 3 quarters · filed 2026-08-12 | $142.61K 10-K · filed 2026-03-25 |
| 2025-09-30 | $36.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $71.13K derived: sum of 2 quarters · filed 2026-08-12 | $106.17K 10-Q · filed 2025-11-14 | $141.21K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $35.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $70.08K 10-Q · filed 2026-08-12 | $105.12K derived: sum of 3 quarters · filed 2026-08-12 | $140.16K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $35.04K 10-Q · filed 2026-05-14 | $70.08K derived: sum of 2 quarters · filed 2026-05-14 | $105.12K derived: sum of 3 quarters · filed 2026-05-14 | $105.12K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $35.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $70.08K derived: sum of 2 quarters · filed 2026-03-25 | $70.08K derived: sum of 3 quarters · filed 2026-03-25 | $70.08K 10-K · filed 2026-03-25 |
| 2024-09-30 | $35.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $35.04K derived: sum of 2 quarters · filed 2025-11-14 | $35.04K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |